By tduggan on December 2, 2016
Researchers found no evidence to suggest that exposure to the antidepressants ‘selective serotonin reuptake inhibitors’ were associated with a delay in MS disability accumulation or progression.
By tduggan on May 16, 2016
via www.centreforbrainhealth.ca Bacteria in the guts of children who had recently developed multiple sclerosis (MS) differed from healthy control children, finds new research from Dr. Helen Tremlett and her University of California research colleagues, including co-PI Dr. Emmanuelle Waubant. These differences were suggestive of a pro-inflammatory environment within the gut bacterial community of the children […]
By tduggan on December 2, 2015
The Multiple Sclerosis Society of Canada and Multiple Sclerosis Scientific Research Foundation have announced new funding that…